Cord blood banking: ethical and cost–benefit aspects

Cord blood represents a new source of stem cells on the edge of fetal and postnatal life. Increasing interest in stem cell therapy has moulded cord blood banking scope, evolving to a multidisciplinary platform exceeding the classic field of haemotherapy. This review intends to re‐analyse this and presents the new aspects of cord blood banking that direct it to a model of cell pharmacy in a globalized world.